REMICADE 100 MG PD. VIAL FOR I.V. INF. 10 ML

Infliximab is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-ALPHA) and is used to treat autoimmune diseases. Infliximab was approved by the U.S. Food and Drug Administration (FDA) for the treatment of Crohn s disease ulcerative colitis psoriasis psoriatic arthritis ankylosing spondylitis and rheumatoid arthritis. It is used off-label outside its FDA approval for Beh�et s disease and other conditions. Infliximab is administered by intravenous infusion typically at six- to eight-week intervals.